Precision Biosciences' Nasdaq debut on Thursday saw the company's stock trading a full 9 percent over the initial offering price. That means the institutional investors who picked up at the stock at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback